Cubist Pharmaceuticals, Inc.’s (CBST) MACD indicator has moved into bearish territory with a reading of -0.0742. The Zacks #5 Rank (“Strong Sell”) stock decreased slightly to $21.62 in morning trade. The Zacks Consensus Estimate on the company’s earnings for the year ending 2011 has decreased by 61 cents over the past month to 85 cents per share.
 
CUBIST PHARM (CBST): Free Stock Analysis Report
 
Zacks Investment Research